British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2005)
- 8 July 2005
- journal article
- practice guideline
- Published by Wiley in HIV Medicine
- Vol. 6 (S2), 1-61
- https://doi.org/10.1111/j.1468-1293.2005.0311b.x
Abstract
No abstract availableThis publication has 221 references indexed in Scilit:
- Antiretroviral Drug Pharmacokinetics in Hepatitis with Hepatic DysfunctionClinical Infectious Diseases, 2005
- Limited Durability of Viral Control following Treated Acute HIV InfectionPLoS Medicine, 2004
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004
- Modeling the Impact of Modified Directly Observed Antiretroviral Therapy on HIV Suppression and Resistance, Disease Progression, and DeathClinical Infectious Diseases, 2004
- Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 InfectionNew England Journal of Medicine, 2004
- Pharmacokinetics of Antiretrovirals in Pregnant WomenClinical Pharmacokinetics, 2004
- Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administrationBritish Journal of Clinical Pharmacology, 2001
- Substitution of a Nonnucleoside Reverse Transcriptase Inhibitor for a Protease Inhibitor in the Treatment of Patients with Undetectable Plasma Human Immunodeficiency Virus Type 1 RNAClinical Infectious Diseases, 2000
- Rationale for the Use of Hydroxyurea as an Anti-Human Immunodeficiency Virus DrugClinical Infectious Diseases, 2000
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997